magnolol has been researched along with Hemorrhagic Shock in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, CH; Shih, HC; Wei, YH | 2 |
2 other study(ies) available for magnolol and Hemorrhagic Shock
| Article | Year |
|---|---|
Magnolol alters cytokine response after hemorrhagic shock and increases survival in subsequent intraabdominal sepsis in rats.
Topics: Animals; Biphenyl Compounds; Cytokines; Interleukin-10; Lignans; Lung Injury; Male; Rats; Rats, Sprague-Dawley; Sepsis; Shock, Hemorrhagic; Time Factors; Tumor Necrosis Factor-alpha | 2003 |
Magnolol alters the course of endotoxin tolerance and provides early protection against endotoxin challenge following sublethal hemorrhage in rats.
Topics: Animals; Antioxidants; Biphenyl Compounds; Endotoxins; Escherichia coli; Immune Tolerance; Interleukin-10; Lignans; Lipid Peroxidation; Lung; Male; Prospective Studies; Random Allocation; Rats; Rats, Sprague-Dawley; Shock, Hemorrhagic; Tumor Necrosis Factor-alpha | 2004 |